KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Sales (2018 - 2025)

Historic Return on Sales for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to 0.01%.

  • Castle Biosciences' Return on Sales fell 300.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.05% for FY2024, which is 3200.0% up from last year.
  • Castle Biosciences' Return on Sales amounted to 0.01% in Q3 2025, which was down 300.0% from 0.05% recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Return on Sales peaked at 0.11% during Q4 2024, and registered a low of 0.92% during Q1 2022.
  • Moreover, its 5-year median value for Return on Sales was 0.19% (2021), whereas its average is 0.24%.
  • Per our database at Business Quant, Castle Biosciences' Return on Sales plummeted by -7300bps in 2022 and then skyrocketed by 6600bps in 2024.
  • Quarter analysis of 5 years shows Castle Biosciences' Return on Sales stood at 0.26% in 2021, then plummeted by -109bps to 0.54% in 2022, then surged by 93bps to 0.04% in 2023, then soared by 385bps to 0.11% in 2024, then crashed by -105bps to 0.01% in 2025.
  • Its Return on Sales stands at 0.01% for Q3 2025, versus 0.05% for Q2 2025 and 0.29% for Q1 2025.